Connection
Robert Page to Cost-Benefit Analysis
This is a "connection" page, showing publications Robert Page has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.121 |
|
|
|
-
Page RL, Ghushchyan V, Read RA, Hartsfield CL, Koch BR, Nair KV. Comparative Effectiveness of Ranolazine Versus Traditional Therapies in Chronic Stable Angina Pectoris and Concomitant Diabetes Mellitus and Impact on Health Care Resource Utilization and Cardiac Interventions. Am J Cardiol. 2015 Nov 01; 116(9):1321-8.
Score: 0.103
-
Slejko JF, Page RL, Sullivan PW. Cost-effectiveness of statin therapy for vascular event prevention in adults with elevated C-reactive protein: implications of JUPITER. Curr Med Res Opin. 2010 Oct; 26(10):2485-97.
Score: 0.018